CytoSorbents Reports Steady Growth in Q2 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Americold to wind down Ahold Delhaize facilities, take $305M charge
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Did Google and Tesla just break AI trade’s bull case?
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- Matador Resources to acquire Paloma Permian for $1.275B
UPDATE: Cytosorbents (CTSO) Tops Q2 EPS View
August 13, 2015 4:50 PM EDT(Updated - August 14, 2015 8:01 AM EDT) (EPS corrected)
Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of $0.05, which was better than the analyst estimate of ($0.11). Revenue for the quarter came in at $733 thousand versus the consensus estimate of $910 thousand.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
... More